Gamitrinib TPP hexafluorophosphate
目录号: PL01326 纯度: ≥98%
CAS No. :1131626-47-5
商品编号 规格 价格 会员价 是否有货 数量
PL01326-1mg 1mg ¥4327.27 请登录
PL01326-5mg 5mg ¥11745.45 请登录
PL01326-10mg 10mg 询价 询价
PL01326-50mg 50mg 询价 询价
PL01326-10mM*1mLinDMSO 10mM*1mLinDMSO ¥26767.27 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Gamitrinib TPP hexafluorophosphate
英文名称
Gamitrinib TPP hexafluorophosphate
英文别名
Gamitrinib TPP hexafluorophosphate;EPA976X5XY;G-TPP Hexafluorophosphate;Gamitrinib hexafluorophosphate;Unii-epa976X5XY
Cas No.
1131626-47-5
分子式
C52H65F6N3O8P2
分子量
1036.03
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Gamitrinib TPP hexafluorophosphate 是一种 Gamitrinib (GA) 线粒体基质的抑制剂。Gamitrinib TPP hexafluorophosphate 是一种靶向线粒体的 HSP90 抑制剂。具有抗癌活性。
生物活性
Gamitrinib TPP hexafluorophosphate is a Gamitrinib (GA) mitochondrial matrix inhibitor. Gamitrinib TPP hexafluorophosphate is a mitochondrial targeted HSP90 inhibitor with anti-cancer activity.
性状
Solid
IC50 & Target[1][2]
HSP90
体外研究(In Vitro)
Gamitrinib TPP (Gamitrinib, G-TPP), a small molecule that combines the Hsp90 ATPase inhibitory module of 17-allylamino geldanamycin (17-AAG) with the mitochondrial-targeting moiety of triphenylphosphonium. Gamitrinib TPP is selectively delivered to mitochondria and does not affect Hsp90 homeostasis outside the organelle. Within a 16-hour exposure, concentrations of Gamitrinib TPP of 15-20 μM indistinguishably kill patient-derived and cultured glioblastoma cell lines. This cell death response has the hallmarks of mitochondrial apoptosis, with loss of organelle inner membrane potential, release of cytochrome c in the cytosol, activation of initiator caspase-9 and effector caspase-3 and caspase-7, and cellular reactivity for annexin V. has not independently confirmed the accuracy of these methods. They are for reference on
体内研究(In Vivo)
Whether the combination of TRAIL plus Gamitrinib TPP (Gamitrinib, G-TPP) has activity against glioblastoma in vivo is studied. Luciferase-expressing U87 glioblastoma cells implanted in the right cerebral striatum of immunocompromised mice give rise to rapidly growing tumors by bioluminescence imaging, and treatment of these mice with vehicle, stereotactic delivery of TRAIL, or systemic administration of suboptimal concentrations of Gamitrinib TPP does not affect tumor growth in vivo. Similarly, systemic monotherapy with Gamitrinib TPP at concentrations (20 mg/kg as daily i.p. injections) that inhibit subcutaneous xenograft tumor growth in mice has no effect on orthotopic glioblastoma growth. In contrast, 2 cycles of intracranial TRAIL combined with systemic Gamitrinib TPP suppresses the growth of established glioblastomas, with no significant animal weight loss throughout trea
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Markus D. Siegelin, et al. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest. 2011 Apr 1; 121(4): 1349–1360.
溶解度数据
In Vitro: DMSO : 50 mg/mL (48.26 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2